Baycip
Baycip

0.55
A generic medicine indicated for respiratory conditions and bacterial infections. Targets bacterial DNA replication processes to ease symptoms and address ongoing infection in the body.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Ciprofloxacin
Reference Brand
Ciprofloxacin
Product Origin
Generic Brand
Product Manufacturer
Cipla Ltd
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antibiotics, Bladder Health
Product Category
Fluoroquinolone
Pharmacological Class
Fluoroquinolone Antibiotic
Manufacturer Description
Developed to mitigate deep-seated bacterial colonizations to support structural clearance and target bacterial topoisomerase.
Mechanism of Action
Inhibits DNA gyrase and topoisomerase IV, breaking bacterial chromosomes and causing rapid structural cell death.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
12 hours
Contraindications
Concurrent tizanidine use, Hypersensitivity to ciprofloxacin
Severe Adverse Events
Tendonitis and tendon rupture — requires immediate medical attention, Peripheral neuropathy — requires immediate medical attention
Common Side Effects
Nausea, Diarrhea, Vomiting
Uncommon Side Effects
Dizziness, Insomnia, Rash
Drug Interactions
Theophylline, Antacids, Tizanidine
Pregnancy Safety Warnings
TGA Category C: Potential risk to arthropathy. Avoid if possible. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for pediatric and adult patients.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Baycip is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Mental Health AU - Latuda Price